U.S. flag

An official website of the United States government

GTR Home > Genes

CHEK2 checkpoint kinase 2

Gene ID: 11200, updated on 14-Nov-2024
Gene type: protein coding
Also known as: CDS1; CHK2; LFS2; RAD53; TPDS4; hCds1; HuCds1; PP1425

Summary

In response to DNA damage and replication blocks, cell cycle progression is halted through the control of critical cell cycle regulators. The protein encoded by this gene is a cell cycle checkpoint regulator and putative tumor suppressor. It contains a forkhead-associated protein interaction domain essential for activation in response to DNA damage and is rapidly phosphorylated in response to replication blocks and DNA damage. When activated, the encoded protein is known to inhibit CDC25C phosphatase, preventing entry into mitosis, and has been shown to stabilize the tumor suppressor protein p53, leading to cell cycle arrest in G1. In addition, this protein interacts with and phosphorylates BRCA1, allowing BRCA1 to restore survival after DNA damage. Mutations in this gene have been linked with Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype usually associated with inherited mutations in TP53. Also, mutations in this gene are thought to confer a predisposition to sarcomas, breast cancer, and brain tumors. This nuclear protein is a member of the CDS1 subfamily of serine/threonine protein kinases. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]

Associated conditions

See all available tests in GTR for this gene

DescriptionTests
A genome-wide association study of optic disc parameters.
GeneReviews: Not available
A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma.
GeneReviews: Not available
Bone osteosarcoma
MedGen: C0585442OMIM: 259500GeneReviews: Not available
not available
Genetic variants associated with breast size also influence breast cancer risk.
GeneReviews: Not available
Genome-wide association analyses of esophageal squamous cell carcinoma in Chinese identify multiple susceptibility loci and gene-environment interactions.
GeneReviews: Not available
Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.
GeneReviews: Not available
Joint analysis of three genome-wide association studies of esophageal squamous cell carcinoma in Chinese populations.
GeneReviews: Not available
Large-scale genotyping identifies 41 new loci associated with breast cancer risk.
GeneReviews: Not available
Li-Fraumeni syndrome 2
MedGen: C5882668OMIM: 609265GeneReviews: Not available
not available
Malignant tumor of prostate
MedGen: C0376358GeneReviews: Not available
not available
Meta-analysis of genome-wide association studies identifies novel loci that influence cupping and the glaucomatous process.
GeneReviews: Not available
Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer.
GeneReviews: Not available

Copy number response

Description
Copy number response
Triplosensitivity

No evidence available (Last evaluated 2020-01-08)

ClinGen Genome Curation Page
Haploinsufficency

Sufficient evidence for dosage pathogenicity (Last evaluated 2020-01-08)

ClinGen Genome Curation PagePubMed

Genomic context

Location:
22q12.1
Sequence:
Chromosome: 22; NC_000022.11 (28687743..28741834, complement)
Total number of exons:
21

Links

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.